pralidoxime and Arrhythmias--Cardiac

pralidoxime has been researched along with Arrhythmias--Cardiac* in 3 studies

Other Studies

3 other study(ies) available for pralidoxime and Arrhythmias--Cardiac

ArticleYear
Protection by a transdermal patch containing eserine and pralidoxime chloride for prophylaxis against (±)-Anatoxin A poisoning in rats.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2014, Jun-02, Volume: 56

    The prophylactic and neuroprotective impact of a transdermal patch containing eserine and pralidoxime chloride (2-PAM) against (±)-Anatoxin A poisoning was investigated using Wistar strain albino rats. Rats were smooth-shaved on the dorsal side, attached with a drug-in-adhesive matrix type prophylactic transdermal patch for 72 h and challenged with subcutaneous injection of three doses (1.0, 1.5 and 2.0×LD50) of (±)-Anatoxin A. The LD50 value of (±)-Anatoxin A was determined to be 1.25mg/kg, and at this particular dose (1.0×LD50) of toxin induced severe clinical symptom including extreme seizures in rats, resulting acute brain injuries in discrete brain regions, leading to 100% mortality within 5 min. The anticonvulsant effect, antiarrythmic effect, nerve conduction study, clinical observations and mortality, neuroprotective effect as well as skin histopathology of the prophylactic transdermal patch against (±)-Anatoxin A poisoning were investigated systematically. It was found that seizures, tachycardia, nerve damage, clinical symptoms, brain injuries and mortality induced by such lethal toxin were effectively prevented by the prophylactic patch treatment up to certain LD50 level. Hence, it could be a choice of potential therapeutic regimen against such lethal poisoning.

    Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Brain; Cyanobacteria Toxins; Male; Neuroprotective Agents; Physostigmine; Pralidoxime Compounds; Rats, Wistar; Seizures; Skin; Transdermal Patch; Tropanes

2014
Cardiac abnormalities in acute organophosphate poisoning.
    Clinical toxicology (Philadelphia, Pa.), 2009, Volume: 47, Issue:3

    Potentially lethal cardiac complications can occur in patients with acute organophosphate poisoning (OPP) and may be overlooked.. Thirty-six patients with acute OPP were studied. Clinical features and the nature of compound involved were recorded. The QT interval was plotted against heart rate to determine the risk for Torsades de Pointes using the Fossa nomogram. Echocardiography was undertaken in 29 patients. Twenty-four-hour Holter monitoring was performed on day 1 in five patients. Thirteen died. Necropsy was performed and hearts were studied both grossly and microscopically.. Gross examination of the heart in 13 cases revealed cardiac discoloration or blotchiness in 12, patchy pericarditis in six, auricular thrombus in six, right ventricular hypertrophy in four, and dilatation in three. On histopathology, all 13 cases had myocardial interstitial edema and vascular congestion, eight had patchy interstitial inflammation, two had patchy myocarditis, and six had a mural thrombus. Sinus tachycardia was the most common electrocardiographic abnormality. The others were corrected QT interval prolongation, ST-T changes, U waves, and ventricular premature contractions. Echocardiography in 29 patients showed minor abnormalities in 10. On Holter monitoring, episodic tachycardia and ST-T changes were observed in four, QT prolongation in three, and episodic bradycardia in two.. Patchy myocardial involvement as a result of direct cardiac toxicity could be one of the factors responsible for serious cardiac complications. As myocardial involvement is patchy, it may not be manifest clinically or on echocardiography. Continuous cardiac monitoring should be undertaken to detect dynamic cardiac changes.

    Topics: Adolescent; Adult; Arrhythmias, Cardiac; Blood Pressure Monitoring, Ambulatory; Body Temperature; Cholinesterase Reactivators; Electrocardiography; Female; Heart Diseases; Hemodynamics; Humans; Insecticides; Male; Middle Aged; Organophosphate Poisoning; Pralidoxime Compounds; Prospective Studies; Radiography; Respiratory Mechanics; Survivors; Young Adult

2009
Repeated asystole following PAM in organophosphate self-poisoning.
    Anaesthesia and intensive care, 1986, Volume: 14, Issue:4

    Topics: Arrhythmias, Cardiac; Heart Arrest; Humans; Insecticides; Male; Middle Aged; Organophosphorus Compounds; Pralidoxime Compounds

1986